Workflow
Pampa Metals Announces $5 million LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) Thenewswireยท2025-06-13 21:55

Core Viewpoint - Pampa Metals Corp. is initiating a non-brokered private placement aiming to raise between $4 million and $5 million through the issuance of shares priced at $0.16 each, with Canaccord Genuity Corp. serving as the financial advisor for this offering [1][6]. Group 1: Offering Details - The private placement will consist of up to 31,250,000 shares offered under the Listed Issuer Financing Exemption, applicable in all Canadian provinces except Quebec [2]. - The offering is scheduled to close around June 27, 2025, and is subject to customary conditions for such transactions [4]. - The shares will not be subject to a Canadian hold period as per applicable securities laws [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to fund exploration at the Piuquenes Project and the Cobrasco Project, as well as for working capital and general corporate purposes [4]. Group 3: Financial Advisor and Fees - Canaccord Genuity Corp. will receive an advisory fee of 1% of the total gross proceeds raised from the offering [6]. - The company may also pay finder's fees of up to 5% in cash and 5% in finder's warrants, with warrants having an exercise price of $0.30 and a term of 2 years [6]. Group 4: Company Background - Pampa Metals is a copper-gold exploration company listed on the Canadian Stock Exchange, Frankfurt, and OTC exchanges [7]. - The company has entered into an agreement to acquire an 80% interest in the Piuquenes Copper-Gold Porphyry Project in Argentina and plans to acquire 100% of Rugby Resources Ltd., which will provide an 80% interest in the Cobrasco Project in Colombia [7].